Zealand Pharma — Juli 2025
-
Også cagrilintide sammen med retraturide
-
Det er biiiiinde galt at de overhovedet tør tage de stoffer
-
Cagrilintide er jo den ene del af CagriSema. Altså amylin delen. Men den er
3 år fra en mulig mono godkendelse -
Retratutide er LLYs 3xg ggg som er i fase 3 og potentielt kan blive godkendt slutningen af 2026.
-
OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1345166/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked
-
(Shorts er reduceret)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind